Overview
Ketamine, once primarily known as a dissociative anesthetic, is now recognized for its profound therapeutic potential, particularly in treating severe depression and other mental health conditions. Its unique mechanism of action, primarily as an NMDA receptor antagonist, allows for rapid antidepressant effects that differ significantly from traditional psychiatric medications. While its anesthetic properties were established in the 1960s, the exploration of its sub-anesthetic doses for mood disorders gained significant traction in the early 21st century, leading to the development of treatments like [[esketamine]] nasal spray. This shift has opened new avenues for individuals suffering from treatment-resistant depression, chronic pain, and PTSD, offering hope where other therapies have failed. However, its use is not without controversy, involving careful medical supervision due to potential side effects and risks of misuse.